NCT01471210 · Interventional trial
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Overall registry status Completed
Phase 1
Conditions Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma
Delaware Valley sites
- Hospital Of The University Of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory